PT2416154T - Método e aparelhos para prever os efeitos de agentes estimulantes de eritropoiese (aee), e para determinar uma dose a ser administrada - Google Patents

Método e aparelhos para prever os efeitos de agentes estimulantes de eritropoiese (aee), e para determinar uma dose a ser administrada

Info

Publication number
PT2416154T
PT2416154T PT100080852T PT10008085T PT2416154T PT 2416154 T PT2416154 T PT 2416154T PT 100080852 T PT100080852 T PT 100080852T PT 10008085 T PT10008085 T PT 10008085T PT 2416154 T PT2416154 T PT 2416154T
Authority
PT
Portugal
Prior art keywords
esa
predicting
apparatuses
administered
dose
Prior art date
Application number
PT100080852T
Other languages
English (en)
Inventor
Chamney Paul
Moissl Ulrich
Wabel Peter
Wieskotten Sebastian
Nier Volker
Original Assignee
Fresenius Medical Care Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Medical Care Deutschland Gmbh filed Critical Fresenius Medical Care Deutschland Gmbh
Publication of PT2416154T publication Critical patent/PT2416154T/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/726—Devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT100080852T 2010-08-03 2010-08-03 Método e aparelhos para prever os efeitos de agentes estimulantes de eritropoiese (aee), e para determinar uma dose a ser administrada PT2416154T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10008085.2A EP2416154B1 (en) 2010-08-03 2010-08-03 Method and apparatuses for predicting the effects of erythropoesis stimulating agents (ESA), and for determining a dose to be administered

Publications (1)

Publication Number Publication Date
PT2416154T true PT2416154T (pt) 2017-08-09

Family

ID=43495255

Family Applications (1)

Application Number Title Priority Date Filing Date
PT100080852T PT2416154T (pt) 2010-08-03 2010-08-03 Método e aparelhos para prever os efeitos de agentes estimulantes de eritropoiese (aee), e para determinar uma dose a ser administrada

Country Status (6)

Country Link
EP (1) EP2416154B1 (pt)
DK (1) DK2416154T3 (pt)
ES (1) ES2636468T3 (pt)
HU (1) HUE035444T2 (pt)
PL (1) PL2416154T3 (pt)
PT (1) PT2416154T (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6864834B2 (ja) * 2017-06-14 2021-04-28 ニプロ株式会社 投与量決定プログラムおよび投与量決定装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2025330C (en) * 1989-09-18 2002-01-22 David W. Osten Characterizing biological matter in a dynamic condition using near infrared spectroscopy
US5280429A (en) 1991-04-30 1994-01-18 Xitron Technologies Method and apparatus for displaying multi-frequency bio-impedance
US6635491B1 (en) * 2000-07-28 2003-10-21 Abbott Labortories Method for non-invasively determining the concentration of an analyte by compensating for the effect of tissue hydration
WO2003045423A1 (en) * 2001-11-28 2003-06-05 Ortho-Mcneil Pharmaceutical, Inc. Erythropoietin dosing regimen for treating anemia
ATE519424T1 (de) 2004-06-29 2011-08-15 Fresenius Medical Care De Gmbh Verfahren und vorrichtung zur bestimmung der hydrierung und/oder des ernährungszustands eines patienten
WO2007033318A2 (en) * 2005-09-13 2007-03-22 Edwards Lifesciences Corporation Continuous spectroscopic measurement of total hemoglobin
US9370324B2 (en) * 2008-11-05 2016-06-21 Fresenius Medical Care Holdings, Inc. Hemodialysis patient data acquisition, management and analysis system
US8192995B2 (en) * 2008-11-13 2012-06-05 Beckman Coulter, Inc. Method of correction of particle interference to hemoglobin measurement

Also Published As

Publication number Publication date
EP2416154B1 (en) 2017-05-03
EP2416154A1 (en) 2012-02-08
PL2416154T3 (pl) 2017-10-31
DK2416154T3 (en) 2017-08-28
ES2636468T3 (es) 2017-10-05
HUE035444T2 (en) 2018-05-28

Similar Documents

Publication Publication Date Title
AP2013007178A0 (en) BCMA-based stratification and therapy for multiplemyeloma patients
TWI561271B (en) Dose setting mechanism and method of using same
DK2608777T3 (en) Compositions and Methods for Cardiac Therapy
EP2788075A4 (en) DEVICE AND METHOD FOR REDUCING THE TRANSTHORACOID IMPEDANCE OF A PATIENT
IL228766A0 (en) Use of compounds of selective androgen receptor modulators for the preparation of a pharmaceutical composition for the treatment of muscle wasting in non-small cell lung cancer patients
PT2726141T (pt) Dispositivo para administração oral de compostos terapêuticos
EP2736474A4 (en) DEVICE AND METHOD FOR NEUROMUSCULAR THERAPY
ZA201401526B (en) Method and formulation for inhalation
EP2739288A4 (en) PROGESTERONE-CONTAINING ORAL PHARMACEUTICAL FORMS AND RELEVANT PROCEDURES
ZA201303605B (en) Compounds and methods for treating pain
EP3479870C0 (en) ELECTRODE FOR MUSCLE STIMULATION
AU338103S (en) Therapeutic device for stimulating muscle contractions
IL220040A0 (en) Methods and low dose regimens for treating red blood cell disorders
EP2661217A4 (en) DEVICES AND METHODS FOR TREATING HEART FAILURE AND RELATED DISEASES
GB201009237D0 (en) New administration method
PL2905268T3 (pl) Kompozycja do traktowania stref zaszpachlowanych gipsem, wykańczanych gipsem albo tynkowanych gipsem i jej zastosowanie do traktowania stref zaszpachlowanych gipsem, wykańczanych gipsem albo tynkowanych gipsem
LT2651410T (lt) Transderminė terapinė sistema, skirta veikliosios medžiagos įvedimui
IL225677A0 (en) A mechanism for determining dosage and a method for using it
IL225673A0 (en) A mechanism for determining dosage and a method for using this mechanism
PL2723344T3 (pl) Złożony środek leczniczy zawierający monoterpen
ZA201301458B (en) Therapeutic agent for pain
EP3406242C0 (en) TLR4 ANTAGONIST FOR USE IN THE TREATMENT OF INCREASED PLASMA AMMONIA LEVELS
PL2416154T3 (pl) Sposób i urządzenia do przewidywania wyników działania czynników pobudzających erytropoezę (ESA), oraz do określania dawki do podawania
GB201107553D0 (en) Composition and methods for the treatment of neuroendocrine and pitutitary tumoars
TWM401446U (en) Skin therapy device structure